AMP Capital Investors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

AMP Capital Investors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-8,574	Closed	-$846K	–	1239
2018 Q1	$846K	Sell	8,574 -4,663	-35%	-$473K	﹤0.01%	903
2017 Q4	$1.39M	Sell	13,237 -2,797	-17%	-$307K	0.01%	852
2017 Q3	$1.81M	Sell	16,034 -1,900	-11%	-$207K	0.01%	769
2017 Q2	$2.02M	Sell	17,934 -987	-5%	-$112K	0.01%	722
2017 Q1	$2.28M	Sell	18,921 -2,613	-12%	-$289K	0.01%	718
2016 Q4	$2.25M	Sell	21,534 -2,419	-10%	-$253K	0.01%	709
2016 Q3	$2.71M	Sell	23,953 -869	-4%	-$115K	0.02%	651
2016 Q2	$3.6M	Buy	24,822 +7,872	+46%	+$1.12M	0.02%	572
2016 Q1	$2.4M	Buy	16,950 +5,692	+51%	+$808K	0.02%	663
2015 Q4	$1.74M	Buy	11,258 +7,958	+241%	+$1.16M	0.01%	745
2015 Q3	$458K	Buy	3,300 +242	+8%	+$33.8K	﹤0.01%	980
2015 Q2	$434K	Buy	+3,058	New	+$436K	﹤0.01%	1003
2014 Q4	–	Sell	-8,500	Closed	-$1.32M	–	1184
2014 Q3	$1.32M	Hold	8,500	–	–	0.01%	844
2014 Q2	$1.17M	Buy	8,500 +5,700	+204%	+$633K	0.01%	883
2014 Q1	$308K	Buy	+2,800	New	+$305K	﹤0.01%	1048

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

AMP Capital Investors's TARO Position: Q2 2018 in Review

AMP Capital Investors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2018, closing a stake of 8,574 shares — an estimated $846K sold.

AMP Capital Investors first reported a position in TARO in Q1 2014 and held it in 15 quarters. The position peaked at $3.6M in Q2 2016. 109 funds tracked by Wall St. Rank hold TARO as of Q2 2018.

AMP Capital Investors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2018 after selling out during the quarter.
AMP Capital Investors sold 8,574 Taro Pharmaceutical Industries Ltd. shares in Q2 2018, an estimated $846K.
AMP Capital Investors first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2014 and held it in 15 quarters.
AMP Capital Investors's Taro Pharmaceutical Industries Ltd. position peaked at $3.6M in Q2 2016.
109 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2018.

Based on AMP Capital Investors's 13F filing for Q2 2018, filed 13 Aug 2018.